Antimicrobial susceptibility and genetic characteristics of Haemophilus infuenzae isolated from patients with respiratory tract infections between 1987 and 2000, including β-lactamase-negative ampicillin-resistant strains

Epidemiology and Infection

Volumn 135, Issue 4, 2007, Pages 665-668

  Qin, L ^a   Watanabe, H ^a   Asoh, N ^a   Watanabe, K ^a   Oishi, K ^a   Mizota, T ^a   Nagatake, T ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; BACTERIAL DNA; BETA LACTAMASE; CEFDINIR; CEFDITOREN; CEFTRIAXONE; LEVOFLOXACIN; ANTIINFECTIVE AGENT; OFLOXACIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL GENETICS; BACTERIAL STRAIN; BACTERIUM ISOLATION; CONTROLLED STUDY; DNA DETERMINATION; ENZYME SYNTHESIS; FREQUENCY ANALYSIS; GENETIC VARIABILITY; HAEMOPHILUS INFLUENZAE; HUMAN; JAPAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PENICILLIN RESISTANCE; PILOT STUDY; PRESCRIPTION; PREVALENCE; PULSED FIELD GEL ELECTROPHORESIS; RESPIRATORY TRACT INFECTION; SAMPLING; ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; CLINICAL TRIAL; DRUG EFFECT; FEMALE; GENETICS; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY;

AMPICILLIN; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; CEFTRIAXONE; FEMALE; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HUMANS; JAPAN; MALE; MICROBIAL SENSITIVITY TESTS; OFLOXACIN; RESPIRATORY TRACT INFECTIONS;

EID: 34247484457     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268806007023     Document Type: Article

References (17)

1. Murphy TF, Apicella MA. Nontypeable Haemophilus influenzae: a review of clinical aspects, surface antigens, and the human immune response to infection. Reviews of Infectious Diseases 1987; 9 1-15.
2. Saito M, et al. Clonal spread of an invasive strain of Haemophilus influenzae type b among nursery contacts accompanied by a high carriage rate of non-disease-associated strains. Journal of Medical Microbiology 2000; 49: 845-847.
3. Felmingham D, Washington J. Trends in the antimicrobial susceptibility of bacterial respiratory tract pathogens - findings of the Alexander Project 1992-1996. Journal of Chemotherapy 1999; 11: 5-21.
4. Karlowsky JA, et al. Antimicrobial surveillance of Haemophilus influenzae in the United States during 2000-2001 leads to detection of clonal dissemination of a beta-lactamase-negative and ampicillin-resistant strain. Journal of Clinical Microbiology 2002; 40: 1063-1066.
5. Hoban D, Felmingham D. The PROTEKT surveillance study: antimicrobial susceptibility of Haemophilus influenzae and Moraxella catarrhalis from community-acquired respiratory tract infections. Journal of Antimicrobial Chemotherapy 2003; 50: 49-59.
6. Suzuki K, Nishimura T, Baba S. Current status of bacterial resistance in the otolaryngology field: Results from the Second Nationwide Survey in Japan. Journal of Incfection and Chemotherapy 2003; 9: 46-52.
7. Ubukata K, et al. Association of amino acid substitutions in penicillin-binding protein 3 with beta-lactam resistance in beta-lactamase-negative ampicillin-resistant Haemophilus influenzae. Antimicrobial Agents and Chemotherapy 2001; 45: 1693-1699.
8. Hasegawa K, et al. Rapidly increasing prevalence of β-lactamase-nonproducing, ampicillin-resistant Haemophilus influenzae type b in patients with meningitis. Antimicrobial Agents and Chemotherapy 2004; 48: 1509-1514.
9. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A4. Wayne, PA: National Committee for Clinical Laboratory Standards, 1998.
10. Yano H, et al. Pulsed-field gel electrophoresis analysis of nasopharyngeal flora in children attending a day care center. Journal of Clinical Microbiology 2000; 38: 625-629.
11. Tenover FC, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: Criteria for bacterial strain typing. Journal of Clinical Microbiology 1995; 33: 2233-2239.
12. Heilmann KP, et al. Decreasing prevalence of beta-lactamase production among respiratory tract isolates of Haemophilus influenzae in the United States. Antimicrobial Agents and Chemotherapy 2005; 49: 2561-2564.
13. Dabernat H, et al. Haemophilus influenzae carriage in children attending French day care centers: A molecular epidemiological study. Journal of Clinical Microbiology 2003; 41: 1664-1672.
14. Marco F, et al. Antimicrobial susceptibilities of 1,730 Haemophilus influenzae respiratory tract isolates in Spain in 1998-1999. Antimicrobial Agents and Chemotherapy 2001; 45: 3226-3228.
15. Seki H, et al. Increasing prevalence of ampicillin-resistant, non-beta-lactamase-producing strains of Haemophilus influenzae in children in Japan. Chemotherapy 1999; 45: 15-21.
16. Watanabe H, et al. Possible high rate of transmission of nontypeable Haemophilus influenzae, including β-lactamase-negative ampicillin-resistant strains, between children and their parents. Journal of Clinical Microbiology 2004; 42: 362-365.
17. Rennie RP, Ibrahim KH. Antimicrobial resistance in Haemophilus influenzae: How can we prevent the inevitable? Commentary on antimicrobial resistance in H. influenzae based on data from the TARGETed surveillance program. Clinical Infectious Diseases 2005; 41 (Suppl. 4): S234-S238.